tiprankstipranks
Advertisement
Advertisement
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
PremiumCompany AnnouncementsAllergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
1M ago
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
Premium
Company Announcements
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
2M ago
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
Premium
Company Announcements
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
2M ago
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
PremiumCompany AnnouncementsAllergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
4M ago
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
Premium
Company Announcements
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
4M ago
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
Premium
Company Announcements
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
4M ago
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
PremiumCompany AnnouncementsAllergy Therapeutics Strengthens Financial Position with New Loan Facility
5M ago
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
Premium
Company Announcements
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
6M ago
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
Premium
Company Announcements
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100